BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7853586)

  • 1. Complications of post-chemotherapy retroperitoneal lymph node dissection.
    Baniel J; Foster RS; Rowland RG; Bihrle R; Donohue JP
    J Urol; 1995 Mar; 153(3 Pt 2):976-80. PubMed ID: 7853586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications of primary retroperitoneal lymph node dissection.
    Baniel J; Foster RS; Rowland RG; Bihrle R; Donohue JP
    J Urol; 1994 Aug; 152(2 Pt 1):424-7. PubMed ID: 8015086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
    Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L;
    J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeat retroperitoneal lymph node dissection for metastatic testis cancer.
    Sexton WJ; Wood CG; Kim R; Pisters LL
    J Urol; 2003 Apr; 169(4):1353-6. PubMed ID: 12629359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer.
    Coogan CL; Hejase MJ; Wahle GR; Foster RS; Rowland RG; Bihrle R; Donohue JP
    J Urol; 1996 Nov; 156(5):1656-8. PubMed ID: 8863564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications of retroperitoneal lymph node dissection in testicular cancer: primary and post-chemotherapy.
    Baniel J; Sella A
    Semin Surg Oncol; 1999 Dec; 17(4):263-7. PubMed ID: 10588855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity?
    Mosharafa AA; Foster RS; Leibovich BC; Bihrle R; Johnson C; Donohue JP
    J Urol; 2003 Jun; 169(6):2126-8. PubMed ID: 12771733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chylous ascites after post-chemotherapy retroperitoneal lymph node dissection: review of the M. D. Anderson experience.
    Evans JG; Spiess PE; Kamat AM; Wood CG; Hernandez M; Pettaway CA; Dinney CP; Pisters LL
    J Urol; 2006 Oct; 176(4 Pt 1):1463-7. PubMed ID: 16952661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, histology and management of intraluminal thrombus at post-chemotherapy retroperitoneal lymph node dissection.
    Johnston P; Beck SD; Cheng L; Masterson TA; Bihrle R; Kesler K; Foster RS
    J Urol; 2013 Sep; 190(3):874-7. PubMed ID: 23517745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications of retroperitoneal lymph node dissection.
    Bihrle R; Donohue JP; Foster RS
    Urol Clin North Am; 1988 May; 15(2):237-42. PubMed ID: 3381370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. En bloc nephrectomy in patients undergoing post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous testis cancer: indications, implications and outcomes.
    Nash PA; Leibovitch I; Foster RS; Bihrle R; Rowland RG; Donohue JP
    J Urol; 1998 Mar; 159(3):707-10. PubMed ID: 9474130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-chemotherapy nerve-sparing laparoscopic retroperitoneal lymph node dissection in stage IIB testicular cancer.
    Kimura Y; Nakamura T; Kawauchi A; Kawabata G; Hongo F; Miki T
    Int J Urol; 2013 Aug; 20(8):837-41. PubMed ID: 23305547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors: indications and limitations.
    Rassweiler JJ; Seemann O; Henkel TO; Stock C; Frede T; Alken P
    J Urol; 1996 Sep; 156(3):1108-13. PubMed ID: 8709319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection.
    Djaladat H; Nichols C; Daneshmand S
    Ann Surg Oncol; 2012 Jul; 19(7):2388-93. PubMed ID: 22395993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopic retroperitoneal lymph node dissection for low-stage cancer: a Washington University update.
    Gardner MW; Roytman TM; Chen C; Brandes SB; Kibel AS; Grubb RL; Bhayani SB; Figenshau RS
    J Endourol; 2011 Nov; 25(11):1753-7. PubMed ID: 21936630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer.
    Mosharafa AA; Foster RS; Koch MO; Bihrle R; Donohue JP
    J Urol; 2004 May; 171(5):1839-41. PubMed ID: 15076289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
    Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP
    J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic retroperitoneal lymph node dissection.
    Janetschek G; Peschel R; Hobisch A; Bartsch G
    J Endourol; 2001 May; 15(4):449-53; discussion 453-5. PubMed ID: 11394460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of bilateral nerve sparing laparoscopic retroperitoneal lymph node dissection for testicular cancer.
    Steiner H; Zangerl F; Stöhr B; Granig T; Ho H; Bartsch G; Peschel R
    J Urol; 2008 Oct; 180(4):1348-52; discussion 1352-3. PubMed ID: 18707723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic retroperitoneal lymphadenectomy after chemotherapy for stage IIB nonseminomatous testicular carcinoma.
    Janetschek G; Hobisch A; Hittmair A; Höltl L; Peschel R; Bartsch G
    J Urol; 1999 Feb; 161(2):477-81. PubMed ID: 9915430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.